LTTS Unveils NVIDIA-Powered Digital Twin Platform for Advanced Respiratory Diagnostics

L&T Technology Services (LTTS) has announced the development of a next-generation AI-powered digital twin platform for respiratory diagnostics and lung navigation, developed in collaboration with NVIDIA.

The company said the platform aims to deliver scalable, low-latency solutions that improve diagnostic precision and expand access to advanced imaging tools for clinicians worldwide.

The solution, to be showcased at the Radiological Society of North America (RSNA) 2025 conference, integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy.

Built on NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimised AI inference, the platform enables detailed visualisation of airways, blood vessels, lobes and lesions, along with interactive simulation and path-planning support for bronchoscopy procedures.

LTTS said its engineering capabilities in medical imaging and proprietary navigation systems allow static CT scans to be converted into dynamic, clinically meaningful digital representations that evolve with patient data. 

The company said such biological digital twins can support planning and navigation for conditions including lung cancer, COPD and infectious diseases.

“AI is reshaping what’s possible in diagnostics and medical technology,” said Alind Saxena, executive director and president of mobility and tech at LTTS. 

“Our collaboration with NVIDIA combines LTTS’ expertise in AI-driven diagnostics and predictive analytics, with NVIDIA’s powerful modeling and visualisation platform. This lets us engineer a digital twin platform that not only enhances diagnostic accuracy but also gives clinicians an immersive, real-time planning tool ultimately helping deliver better outcomes for patients around the world,” Saxena added.

David Niewolny, director of business development for healthcare/medical at NVIDIA, said the partnership demonstrates the potential for accelerated computing in clinical workflows. 

“Working with LTTS to accelerate the development of AI-enabled medical technology demonstrates how NVIDIA is empowering the healthcare industry with accelerated computing and AI innovation,” Niewolny said. 

“LTTS is enabling transformative solutions that bring the vision of real-time AI and biological digital twins powered by NVIDIA to clinical practice, delivering interactive, real-time visualisation and intelligent guidance to help clinicians provide higher-quality care and achieve better outcomes for patients.”